Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

计划入组 120 人 · 首次发布于 2023 年 7 月 20 日

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

计划入组 8 人 · 首次发布于 2021 年 6 月 15 日

DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC

计划入组 188 人 · 首次发布于 2024 年 1 月 5 日

Perfluoropropane-albumin Microspheres

Rx

Human albumin microspheres

166-Ho microspheres

ABK Biomedical Secures $35M Series D to Advance Eye90 Microspheres for Liver Cancer Treatment

University of Missouri Launches First On-Campus Radiopharmaceutical Clinical Trial Using Eye90 Microspheres for Liver Cancer

ABK Biomedical's Eye90 Microspheres Receives FDA Clearance to Advance Pivotal HCC Trial